Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection

BACKGROUND: Aberrant expression of interleukin-35 (IL-35) has been implicated in dampening antitumour immunity. The aim of this study was to explore the prognostic significance of IL-35 expression in patients with hepatocellular carcinoma (HCC) following curative resection. Furthermore, we aimed to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Fu, Yi-Peng, Yi, Yong, Cai, Xiao-Yan, Sun, Jian, Ni, Xiao-Chun, He, Hong-Wei, Wang, Jia-Xing, Lu, Zhu-Feng, Huang, Jin-Long, Cao, Ya, Zhou, Jian, Fan, Jia, Qiu, Shuang-Jian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2016
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984866/
https://ncbi.nlm.nih.gov/pubmed/27002937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.47
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak